New! Sign up for our free email newsletter.
Science News
from research organizations

Body's 'message in a bottle' delivers targeted cancer treatment

Date:
May 20, 2024
Source:
Karolinska Institutet
Summary:
Researchers have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells use to communicate. A new study shows that the treatment reduces tumor growth and improves survival in mice.
Share:
FULL STORY

Researchers at Karolinska Institutet in Sweden have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells use to communicate. A new study published in Nature Biomedical Engineering shows that the treatment reduces tumour growth and improves survival in mice.

When our cells communicate, they send out small membrane bubbles known as extracellular vesicles which contain various signalling molecules. Interest in these tiny bubbles, sometimes referred to as the body's 'message in a bottle', has increased in recent years as they could be used to deliver medicines.

Antibodies seek out tumours

Researchers at Karolinska Institutet have now created a targeted cancer treatment by loading these bubbles with a chemotherapeutic drug and attaching antibodies against tumours to their surface. In addition to targeting tumour cells, the antibodies act as a form of immunotherapy, resulting in an enhanced therapeutic effect. The treatment reduced tumour growth and improved survival when given as an injection to mice with breast cancer or melanoma.

"By attaching different antibodies to extracellular vesicles, we can target them to virtually any tissue and we can load them with other types of drugs as well," says Oscar Wiklander, physician and researcher at the Department of Laboratory Medicine, Karolinska Institutet, and joint first author with Doste Mamand, researcher at the same department. "Therefore, the treatment has the potential to be used against other diseases and cancer types."

More effective and fewer side effects

The hope is that the new treatment will be more specific and effective in eliminating tumour cells without affecting healthy tissue, compared to current treatment strategies. The researchers plan to investigate whether different combinations of antibodies and drugs can further improve treatment.

"Among other things, we want to investigate the possibility of delivering mRNA as an anticancer drug," says the study's last author Samir EL Andaloussi, Professor at the Department of Laboratory Medicine, Karolinska Institutet. "Ultimately, we hope this can lead to a new treatment platform that can improve treatment efficacy and reduce side effects in difficult-to-treat diseases, especially cancer."

The research was mainly funded by the Swedish Cancer Society, the Swedish Research Council, the European Research Council (ERC) and CIMED. Several of the authors have a financial interest in Evox Therapeutics.


Story Source:

Materials provided by Karolinska Institutet. Note: Content may be edited for style and length.


Journal Reference:

  1. Oscar P. B. Wiklander, Doste R. Mamand, Dara K. Mohammad, Wenyi Zheng, Rim Jawad Wiklander, Taras Sych, Antje M. Zickler, Xiuming Liang, Heena Sharma, Andrea Lavado, Jeremy Bost, Samantha Roudi, Giulia Corso, Angus J. Lennaárd, Manuchehr Abedi-Valugerdi, Imre Mäger, Evren Alici, Erdinc Sezgin, Joel Z. Nordin, Dhanu Gupta, André Görgens, Samir EL Andaloussi. Antibody-displaying extracellular vesicles for targeted cancer therapy. Nature Biomedical Engineering, 2024; DOI: 10.1038/s41551-024-01214-6

Cite This Page:

Karolinska Institutet. "Body's 'message in a bottle' delivers targeted cancer treatment." ScienceDaily. ScienceDaily, 20 May 2024. <www.sciencedaily.com/releases/2024/05/240520122751.htm>.
Karolinska Institutet. (2024, May 20). Body's 'message in a bottle' delivers targeted cancer treatment. ScienceDaily. Retrieved June 13, 2024 from www.sciencedaily.com/releases/2024/05/240520122751.htm
Karolinska Institutet. "Body's 'message in a bottle' delivers targeted cancer treatment." ScienceDaily. www.sciencedaily.com/releases/2024/05/240520122751.htm (accessed June 13, 2024).

Explore More

from ScienceDaily

RELATED STORIES